GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.61 $5.48 Thursday, 18th Apr 2024 QURE stock ended at $4.71. This is 0.86% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 2.26% from a day low at $4.66 to a day high of $4.76.
90 days $4.61 $6.85
52 weeks $4.61 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
2023-11-22 $6.78 $6.89 $6.59 $6.79 431 748
2023-11-21 $6.89 $6.95 $6.72 $6.73 577 753
2023-11-20 $6.95 $7.24 $6.83 $6.97 653 245
2023-11-17 $6.48 $6.96 $6.38 $6.89 640 222
2023-11-16 $6.62 $6.64 $6.34 $6.43 577 415
2023-11-15 $6.61 $7.16 $6.59 $6.66 878 981
2023-11-14 $6.31 $6.64 $6.25 $6.62 1 251 744
2023-11-13 $6.01 $6.07 $5.70 $6.00 558 857
2023-11-10 $6.27 $6.27 $5.75 $6.06 921 274
2023-11-09 $6.65 $6.73 $6.25 $6.25 910 419
2023-11-08 $7.10 $7.12 $6.50 $6.51 1 590 545
2023-11-07 $6.03 $6.92 $6.03 $6.89 1 529 547
2023-11-06 $6.12 $6.19 $5.77 $6.11 1 083 650
2023-11-03 $5.79 $6.36 $5.79 $6.12 1 212 065
2023-11-02 $5.84 $5.94 $5.70 $5.72 988 735
2023-11-01 $5.55 $5.77 $5.49 $5.76 866 874
2023-10-31 $5.65 $5.74 $5.49 $5.70 691 699
2023-10-30 $5.66 $5.85 $5.66 $5.68 568 011
2023-10-27 $5.83 $5.83 $5.59 $5.63 738 325
2023-10-26 $5.84 $6.02 $5.78 $5.82 717 030
2023-10-25 $6.14 $6.16 $5.84 $5.84 451 246
2023-10-24 $6.05 $6.31 $6.05 $6.19 558 870
2023-10-23 $6.08 $6.09 $5.87 $6.00 715 389
2023-10-20 $6.19 $6.36 $6.14 $6.18 527 865
2023-10-19 $6.19 $6.31 $6.12 $6.18 725 862
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT